Carmat SA
Carmat SA designs and develops total artificial heart for patients with advanced heart failure in France and internationally. The company offers Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.
Carmat SA (CXT) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2023: 0.625x
Based on the latest financial reports, Carmat SA (CXT) has a cash flow conversion efficiency ratio of 0.625x as of June 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-15.33 Million) by net assets (€-24.54 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Carmat SA - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Carmat SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Carmat SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Carmat SA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Modern Healthcare Technology Holdings Limited
F:M3L
|
0.149x |
|
Correlate Infrastructure Partners Inc
OTCQB:CIPI
|
-0.123x |
|
Topvision Eye Specialist Berhad
KLSE:0332
|
N/A |
|
Berto Acquisition Corp. Warrant
NASDAQ:TACOW
|
0.000x |
|
Novolog Pharm-Up 1966 Ltd
TA:NVLG
|
0.040x |
|
Urban-Gro Inc
NASDAQ:UGRO
|
0.056x |
|
Coca Cola HBC AG
LSE:CCH
|
0.256x |
|
Star Navigation Systems Group Ltd
PINK:SNAVF
|
0.140x |
Annual Cash Flow Conversion Efficiency for Carmat SA (2013–2024)
The table below shows the annual cash flow conversion efficiency of Carmat SA from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €-51.13 Million | €-43.31 Million | 0.847x | -30.68% |
| 2023-12-31 | €-43.76 Million | €-53.48 Million | 1.222x | +104.42% |
| 2022-12-31 | €1.97 Million | €-54.40 Million | -27.628x | -722.14% |
| 2021-12-31 | €-13.55 Million | €-60.17 Million | 4.441x | -30.98% |
| 2020-12-31 | €-6.69 Million | €-43.03 Million | 6.434x | +491.15% |
| 2019-12-31 | €24.47 Million | €-40.24 Million | -1.645x | +67.76% |
| 2018-12-31 | €7.48 Million | €-38.17 Million | -5.102x | -827.89% |
| 2017-12-31 | €44.15 Million | €-24.28 Million | -0.550x | +59.08% |
| 2016-12-31 | €15.83 Million | €-21.27 Million | -1.344x | +89.03% |
| 2015-12-31 | €1.40 Million | €-17.19 Million | -12.248x | -407.32% |
| 2014-12-31 | €7.76 Million | €-18.75 Million | -2.414x | -269.34% |
| 2013-12-31 | €14.74 Million | €-9.64 Million | -0.654x | -- |